Researchers from North Carolina State University have synthesized an analog of lipoxazolidinone A, a small molecule that is effective against drug-resistant bacteria such as MRSA. This molecule, a new synthetic compound inspired by a natural product, could be a useful chemical tool for studying other Gram-positive infections and may have implications for future drug creation.
Lipoxazolidinone A is a natural product which had been previously isolated from bacteria living in marine sediments. It is a secondary metabolite – a small molecule produced by the bacteria that isn’t key to its survival but is produced for a secondary purpose, like defense. When lipoxazolidinone A was initially isolated, researchers noted that it seemed effective against Gram-positive bacteria, like MRSA.
NC State chemist Joshua Pierce aimed to confirm those original findings and understand how the molecule’s structure correlated to its function; in short, he wanted to recreate the molecule to see what portions were directly responsible for its anti-microbial properties and then potentially improve upon that structure.
Pierce, along with current NC State graduate student Kaylib Robinson and former students Jonathan Mills and Troy Zehnder, used novel chemical tools to synthesize lipoxazolidinone A in the lab. They were able to confirm that its chemical structure matched what the initial researchers had indicated, then they worked to identify the portion of the molecule that was responsible for the activity against Gram-positive bacteria. Their result was a compound with improved potency, JJM-35.
They tested JJM-35 against a panel of resistant and non-resistant bacteria. When tested against MRSA in vitro, they found that the synthesized molecule was up to 50 times more effective than the natural product against several bacterial strains. Additionally, they found that the molecule was often more effective against resistant bacterial strains than it was against nonresistant strains.
“An exciting additional aspect of this work was that we identified that these molecules may function by inhibiting multiple biosynthetic pathways directly or indirectly,” says Pierce. “This means that bacteria may have difficulty developing resistance to potential drugs developed from these molecules.”
While more work is needed, Pierce hopes that JJM-35 and similar compounds can be used as tools to study other Gram-positive bacteria and provide a platform for the development of a novel class of anti-infective agents.
“At this point, we have a chemical scaffold – a starting piece of the puzzle. We know that this piece is effective, and so right now all efforts are focused on evaluating the properties of these molecules and their in vivo efficacy,” says Pierce. “The hope is that we can build upon this scaffold to create drugs that are effective against MRSA and other resistant bacteria at a time of dire need for antimicrobial development while also increasing the spectrum of activity.”
Receive an email update when we add a new ANTIMICROBIAL RESISTANCE article.
The Latest on: Antimicrobial development
via Google News
The Latest on: Antimicrobial development
- Antimicrobial Resistance Policy Review and Development Framework on October 25, 2018 at 5:00 pm
This publication provides reference and general guidance for countries, specifically policy makers and official, to draft and implement policies on antimicrobial resistance (AMR) and antimicrobial use ... […]
- Antimicrobial resistance ‘must become a Government priority’ on October 21, 2018 at 4:23 pm
Antimicrobial-resistant infections currently claim at least ... on implementing practical policies to reverse the worrying exodus from AMR research and development and both Government and industry sho... […]
- Antimicrobial Protection Additives for Adhesives Market: Emerging Economies Expected to Influence Growth Until 2028 on October 11, 2018 at 3:17 am
flag=S&rep_id=1566 Antimicrobial Protection Additives for Adhesives Market: Dynamics Growing construction and infrastructural development in developing countries is leading to growth in consumption of ... […]
- 5 Things to Know About Antimicrobial Resistance on October 4, 2018 at 5:00 pm
Here are 5 things to know about antimicrobial resistance (AMR): 1. Drug development to create new antibiotics is running thin, but the FDA hopes to change that. Last month, the FDA announced a new, 4- ... […]
- Antimicrobial Wound Dressing Market - Size, Share, Outlook, and Forecast till 2026 on September 30, 2018 at 5:00 pm
this in turn boosting growth of the antimicrobial wound dressing market. Recent advances in antiseptic technology have led to the development of a number of products that are less harmful to healthy t... […]
- Antimicrobial Additives Market Size, Share, Top Growth Factors, Market... on September 25, 2018 at 3:11 am
(MENAFN Editorial) Global Antimicrobial Additives Market Information by Type (Organic, Inorganic), Application (Plastics, Paints & Coatings, Rubber & Silicone, Fabric), End-Use Industry (Healthcare, C... […]
- Development of Silicone Hydrogel Antimicrobial Contact Lenses with Mel4 Peptide Coating on September 16, 2018 at 5:00 pm
SIGNIFICANCE This study investigated the development of an antimicrobial coating on silicone hydrogel contact lenses that may have the capacity to reduce contact lens–related infection and inflammator... […]
- FDA hopes new payment models would spark antibiotic drug development on September 15, 2018 at 5:28 pm
An estimated two million people in the U.S., develop serious infections caused by antimicrobial-resistant bacteria each year, according to the Centers for Disease Control and Prevention, resulting in ... […]
- Soligenix to Present at the 2018 ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance on August 29, 2018 at 3:21 am
PRINCETON, N.J., Aug. 29, 2018 /PRNewswire/ -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rar... […]
via Bing News